To study the impact of Z-palatopharyngoplasty (ZPPP) plus radiofrequency tongue base reduction (RFBOT) on middle ear pressures (MEPs) and middle ear volumes (MEVs). METHOD: The study population included 47 patients (42 men, 5 women; mean age 40.8 years) who underwent a ZPPP combined with RFBOT for obstructive sleep apnea/hypopnea syndrome (OSAHS). All subjects had normal eardrums and no previous history of chronic ear disease. Pure-tone audiometry and tympanometry were performed pre-operatively, and at 3 days, 7 days, 1 month, and 3 months post-operatively. Baseline and postoperative MEPs in decipascals (daPa) and MEVs in milliliters (mL) were compared. RESULTS: Twelve patients (25.5%) reported otologic complaints such as ear pressure and/or otalgia within one week following ZPPP plus RFBOT. No permanent otologic discomfort or long-term velopharyngeal insufficiency occurred. The mean MEP (daPa) of the right ears preoperatively was -5.11ϩ-23.72 versus postoperative values of -33.30ϩ-72.08, -13.72ϩ-49.58, -5.00ϩ-21.62, and -2.45ϩ-21.24 on day 3, day 7, 1 month, and 3 months, respectively. The mean preoperative MEV (mL) of the right ears was 0.54ϩ-0.32 versus 0.49ϩ-0.29, 0.51ϩ-0.30, 0.510.30 and 0.550.31 postoperatively on day 3, day 7, and at 1 and 3 months. The mean MEP (daPa) of the left ears preoperatively was -1. 49ϩ-13.18 versus -24.68ϩ-54.90, -6.60ϩ-25.98, 2.23ϩ-13.01, and 0.21ϩ-12.55 post-operatively on day 3, day 7 and at 1 and 3 months. The mean preoperative MEV (mL) of the left ears was 0.50ϩ-0.35 versus 0.45ϩ-0.29, 0.47ϩ-0.29, 0.47ϩ-0.28, and 0.48ϩ-0.27 postoperatively on day 3, day 7 and at 1 and 3 months postoperatively. Statistical analysis was performed by repeated measures of ANOVA. The results showed there was no statistical significance after postoperative day 7. CONCLUSION: ZPPP combined with RFBOT for the treatment of OSAHS induces changes in MEPs and MEVs. However, the changes were reversible and not significant after 3 months follow-up.
OBJECTIVE: Treatment of hypopharyngeal collapse of upper airway is a surgical challenge in obstructive sleep apnea management in CPAP intolerants. Temporary procedures addressing hypopharynx are invasive and of low efficacy. METHOD: Study design: A prospective nonrandomized, multicenter study to evaluate feasibility, safety and efficacy of tongue advancement procedure was conducted. Materials and Methods: 19 OSA patients with an apnea-hypopnea index (AHI) between 15 and 50 with CPAP intolerance were included into the study. Objective measurements of preoperative screening and baseline polysomnography (PSG) were measured. 3-months and 6-months postoperative PSG were recorded. Preoperative and postoperative home sleep studies, cephalographs and videoendoscopy were performed. Additionally, the subjects completed the Epworth Sleepiness Scale (ESS), Patient and Bed Partner Snoring Questionnaire (VAS), Functional Outcomes of Sleep Questionnaire (FOSQ) and Throat questionnaire. We used a novel method of swallowing forces measuring. RESULTS: AHI dropped from 33.8 at baseline to 18.6 at 3-months follow-up and to 24.3 at 6-months PSG, respectively. Overall surgical success was 38.9%. ESS decreased form 11.4 to 6.1 and 7.4, respectively. Snoring intensity was reduced to 46.3 and 46.4 respectively. Life quality was improved of 14.3 and 15.6% respectively. CONCLUSION: The rates of surgical success, feasibility and safety were satisfactory. Further technical device improvement is necessary and must be based on the new information of tongue forces. When solving technical issues the tongue implants could play a role in multilevel surgery in the future.
